Optimal use of prostate specific antigen for prostate cancer screening

Vojnosanit Pregl. 2013 May;70(5):501-3. doi: 10.2298/vsp1305501m.

Authors

Ranko Miocinović¹, Uros Bumbasirević, Miroslav L Djordjević, Nebojsa Bojanić, Bogomir Milojević, Cane Tulić, Andrew J Stephenson

Affiliation

¹ Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.

PMID: 23789290
DOI: 10.2298/vsp1305501m

No abstract available

MeSH terms

Humans
Male
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / diagnosis*
Risk Assessment

Substances

Prostate-Specific Antigen